Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Shepp

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Pathology|July 13, 2001
Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtrationS M Lipson, D H Shepp, M E Match, et al.
The Journal of Infectious Diseases|July 1, 1996
Cytomegalovirus glycoprotein B groups associated with retinitis in AIDSD H Shepp, M E Match, A B Ashraf, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1997
Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistanceS M Lipson, M Soni, F X Biondo, et al.
Journal of Clinical Microbiology|July 16, 1999
Evaluation of the PrimeCapture CMV DNA detection plate system for detection of cytomegalovirus in clinical specimensE H Davoli, S M Lipson, M E Match, et al.
Clinical and Diagnostic Virology|August 1, 1997
Significance of leukocyte concentration in the performance of the quantitative cytomegalovirus (CMV) antigenemia assayS M Lipson, A Toro, M Lotlikar, et al.
Annals of Internal Medicine|September 1, 1985
Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumoniaD H Shepp, P S Dandliker, P de Miranda, et al.
The New England Journal of Medicine|January 14, 1988
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantationJ D Meyers, E C Reed, D H Shepp, et al.
Antiviral Therapy|February 22, 2000
Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDSH H Balfour, C V Fletcher, A Erice, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1996
Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infectionM R Wallace, R B Moss, H J Beecham, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Pathology|July 13, 2001
Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtrationS M Lipson, D H Shepp, M E Match, et al.
The Journal of Infectious Diseases|July 1, 1996
Cytomegalovirus glycoprotein B groups associated with retinitis in AIDSD H Shepp, M E Match, A B Ashraf, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1997
Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistanceS M Lipson, M Soni, F X Biondo, et al.
Journal of Clinical Microbiology|July 16, 1999
Evaluation of the PrimeCapture CMV DNA detection plate system for detection of cytomegalovirus in clinical specimensE H Davoli, S M Lipson, M E Match, et al.
Clinical and Diagnostic Virology|August 1, 1997
Significance of leukocyte concentration in the performance of the quantitative cytomegalovirus (CMV) antigenemia assayS M Lipson, A Toro, M Lotlikar, et al.
Annals of Internal Medicine|September 1, 1985
Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumoniaD H Shepp, P S Dandliker, P de Miranda, et al.
The New England Journal of Medicine|January 14, 1988
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantationJ D Meyers, E C Reed, D H Shepp, et al.
Antiviral Therapy|February 22, 2000
Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDSH H Balfour, C V Fletcher, A Erice, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1996
Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infectionM R Wallace, R B Moss, H J Beecham, et al.
Pageof 4